-
2
-
-
0027343763
-
Strategies for prevention of anthracycline cardiotoxicity
-
Basser RL, Green MD (1993) Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev 19:57-77
-
(1993)
Cancer Treat Rev
, vol.19
, pp. 57-77
-
-
Basser, R.L.1
Green, M.D.2
-
4
-
-
0027169157
-
Cardioprotection by ICRF-187 against high dose anthracycline toxicity in children with malignant disease
-
Bu'Lock FA, Gabriel HM, Oakhill A, Mott MG, Martin RP (1993) Cardioprotection by ICRF-187 against high dose anthracycline toxicity in children with malignant disease. Br Heart J 70:185-188
-
(1993)
Br Heart J
, vol.70
, pp. 185-188
-
-
Bu'Lock, F.A.1
Gabriel, H.M.2
Oakhill, A.3
Mott, M.G.4
Martin, R.P.5
-
5
-
-
0028927953
-
Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology
-
Bu'Lock FA, Mott MG, Oakhill A, Martin P (1995) Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 73:340-350
-
(1995)
Br Heart J
, vol.73
, pp. 340-350
-
-
Bu'Lock, F.A.1
Mott, M.G.2
Oakhill, A.3
Martin, P.4
-
6
-
-
0033003848
-
Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study
-
Bu'Lock FA, Mott MG, Oakhill A, Martin RP (1999) Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: a prospective study. Pediatr Cardiol 20:252-263
-
(1999)
Pediatr Cardiol
, vol.20
, pp. 252-263
-
-
Bu'Lock, F.A.1
Mott, M.G.2
Oakhill, A.3
Martin, R.P.4
-
7
-
-
0035328363
-
Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children
-
Eidem BW, Sapp BG, Suarez CR, Cetta F (2001) Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol 87:1120-1122
-
(2001)
Am J Cardiol
, vol.87
, pp. 1120-1122
-
-
Eidem, B.W.1
Sapp, B.G.2
Suarez, C.R.3
Cetta, F.4
-
8
-
-
0031760629
-
Doxorubicin cardiotoxicity in children: Comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration
-
Ewer MS, Jaffe N, Ried H, Zietz HA, Benjamin RS (1998) Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration. Med Pediatr Oncol 31:512-515
-
(1998)
Med Pediatr Oncol
, vol.31
, pp. 512-515
-
-
Ewer, M.S.1
Jaffe, N.2
Ried, H.3
Zietz, H.A.4
Benjamin, R.S.5
-
9
-
-
0036623690
-
Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis
-
Gharib MI, Burnett AK (2002) Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail 4:23-242
-
(2002)
Eur J Heart Fail
, vol.4
, pp. 23-242
-
-
Gharib, M.I.1
Burnett, A.K.2
-
10
-
-
0001115439
-
Anthracycline-induced cardiotoxicity in children and young adults
-
Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE (1998) Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol/Hematol 4:53-68
-
(1998)
Crit Rev Oncol/Hematol
, vol.4
, pp. 53-68
-
-
Giantris, A.1
Abdurrahman, L.2
Hinkle, A.3
Asselin, B.4
Lipshultz, S.E.5
-
11
-
-
0031906718
-
Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines
-
Hasinoff BB, Hellmann K, Herman EH, Ferrans VJ (1998) Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines. Curr Med Chem 5:1-28
-
(1998)
Curr Med Chem
, vol.5
, pp. 1-28
-
-
Hasinoff, B.B.1
Hellmann, K.2
Herman, E.H.3
Ferrans, V.J.4
-
12
-
-
0035172420
-
Recent advances in the prevention of anthracycline cardiotoxicity in childhood
-
Iarussi D, Indolfi P, Casale F, Coppolino P, Tedesco MA, DiTullio MT (2001) Recent advances in the prevention of anthracycline cardiotoxicity in childhood. Curr Med Chem 8:1649-1660
-
(2001)
Curr Med Chem
, vol.8
, pp. 1649-1660
-
-
Iarussi, D.1
Indolfi, P.2
Casale, F.3
Coppolino, P.4
Tedesco, M.A.5
DiTullio, M.T.6
-
13
-
-
0034814549
-
Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood
-
Iarussi D, Galderisi M, Raitti G, Tedesco MA, Indolfi P, Casale F, DiTullio MT, DeDinitiis O, Iacono A (2001) Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood. Clin Cardiol 24:663-669
-
(2001)
Clin Cardiol
, vol.24
, pp. 663-669
-
-
Iarussi, D.1
Galderisi, M.2
Raitti, G.3
Tedesco, M.A.4
Indolfi, P.5
Casale, F.6
DiTullio, M.T.7
DeDinitiis, O.8
Iacono, A.9
-
14
-
-
0030025542
-
Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring
-
Johnson GL, Moffett CB, Geil JD, Greenwood MF, Noonam JA (1996) Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring. J Pediatr Hematol/Oncol 18:72-75
-
(1996)
J Pediatr Hematol/Oncol
, vol.18
, pp. 72-75
-
-
Johnson, G.L.1
Moffett, C.B.2
Geil, J.D.3
Greenwood, M.F.4
Noonam, J.A.5
-
15
-
-
0025942977
-
Cardioxane-ICRF-187. Towards anticancer drug specificity through selective toxicity reduction
-
Koning J, Palmer P, Franks CR, Mulder DE, Speyer JL, Green MD, Hellmann K (1991) Cardioxane-ICRF-187. Towards anticancer drug specificity through selective toxicity reduction. Cancer Treat Rev 18:1-19
-
(1991)
Cancer Treat Rev
, vol.18
, pp. 1-19
-
-
Koning, J.1
Palmer, P.2
Franks, C.R.3
Mulder, D.E.4
Speyer, J.L.5
Green, M.D.6
Hellmann, K.7
-
16
-
-
0032966349
-
Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors
-
Lippens RJJ (1999) Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors. Pediatr Hematol Oncol 16:131-139
-
(1999)
Pediatr Hematol Oncol
, vol.16
, pp. 131-139
-
-
Lippens, R.J.J.1
-
17
-
-
0026031848
-
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
-
Lipshultz SE, Colan SD, Gelber RD, Peres-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815
-
(1991)
N Engl J Med
, vol.324
, pp. 808-815
-
-
Lipshultz, S.E.1
Colan, S.D.2
Gelber, R.D.3
Peres-Atayde, A.R.4
Sallan, S.E.5
Sanders, S.P.6
-
18
-
-
0028989408
-
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer
-
Lipschultz SE, Lipsitz SR, Mone SM et al (1995) Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743
-
(1995)
N Engl J Med
, vol.332
, pp. 1738-1743
-
-
Lipschultz, S.E.1
Lipsitz, S.R.2
Mone, S.M.3
-
19
-
-
0037087687
-
Doxorubicin administration by continuous infusion is not cardioprotective: The dana-farber 91-01 acute lymphoblastic leukemia protocol
-
Lipshultz SE, Giantris AL, Lipsitz SR, Dalton VC, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Mogharbi A, Samson Y, Schorin SM, Gelber RD, Sallan SE, Colan SD (2002) Doxorubicin administration by continuous infusion is not cardioprotective: the dana-farber 91-01 acute lymphoblastic leukemia protocol. J Clin Oncol 20:1677-1682
-
(2002)
J Clin Oncol
, vol.20
, pp. 1677-1682
-
-
Lipshultz, S.E.1
Giantris, A.L.2
Lipsitz, S.R.3
Dalton, V.C.4
Asselin, B.L.5
Barr, R.D.6
Clavell, L.A.7
Hurwitz, C.A.8
Mogharbi, A.9
Samson, Y.10
Schorin, S.M.11
Gelber, R.D.12
Sallan, S.E.13
Colan, S.D.14
-
20
-
-
0742329379
-
Dexrazoxane reduces incidence of doxorubicin-associated acute myocardiocyte injury in children with acute lymphoblastic leukemia (ALL)
-
Lipshultz SE, Colan SD, Silverman LB, Levy DE, Dalton VK, Rifai N, Lipsitz SR, Gelber RD, Salan SE (2002) Dexrazoxane reduces incidence of doxorubicin-associated acute myocardiocyte injury in children with acute lymphoblastic leukemia (ALL). J Clin Oncol 15:1544-1552
-
(2002)
J Clin Oncol
, vol.15
, pp. 1544-1552
-
-
Lipshultz, S.E.1
Colan, S.D.2
Silverman, L.B.3
Levy, D.E.4
Dalton, V.K.5
Rifai, N.6
Lipsitz, S.R.7
Gelber, R.D.8
Salan, S.E.9
-
21
-
-
0031919240
-
Late cariotoxicity following anthracycline therapy for childhood cancer
-
Nysom K, Colan CD, Lipshultz SE (1998) Late cariotoxicity following anthracycline therapy for childhood cancer. Prog Pediatr Cardiol 8:121-138
-
(1998)
Prog Pediatr Cardiol
, vol.8
, pp. 121-138
-
-
Nysom, K.1
Colan, C.D.2
Lipshultz, S.E.3
-
22
-
-
0003547951
-
-
W.B. Saunders, Philadelphia, PA, USA
-
Otto CM, Pearlman AS (1995) Textbook of clinical echocardiography, 1st edn. W.B. Saunders, Philadelphia, PA, USA
-
(1995)
Textbook of Clinical Echocardiography, 1st Edn.
-
-
Otto, C.M.1
Pearlman, A.S.2
-
23
-
-
0000166802
-
ICRF-187 (Cardioxane) protection against doxorubicin induced cardiomyopathy in pediatric osteosarcoma patients
-
Rubio ME, Wiegman A, Naeff MS (1995) ICRF-187 (Cardioxane) protection against doxorubicin induced cardiomyopathy in pediatric osteosarcoma patients. Proc Am Soc Clin Oncol 14:1403a
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
-
-
Rubio, M.E.1
Wiegman, A.2
Naeff, M.S.3
-
24
-
-
0033113566
-
Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer
-
Seymour L, Bramwell V, Moran LA (1999) Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. Cancer Prev Control 3:145-159
-
(1999)
Cancer Prev Control
, vol.3
, pp. 145-159
-
-
Seymour, L.1
Bramwell, V.2
Moran, L.A.3
-
26
-
-
0036402578
-
Polyethylene glycolliposomal doxorubicin. A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma
-
Sharpe M, Easthope SE, Keating GM, Lamb HM (2002) Polyethylene glycolliposomal doxorubicin. A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 62:2089-2126
-
(2002)
Drugs
, vol.62
, pp. 2089-2126
-
-
Sharpe, M.1
Easthope, S.E.2
Keating, G.M.3
Lamb, H.M.4
-
27
-
-
0030998937
-
Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: Preliminary results
-
Schiavetti A, Castello MA, Versacci P, Varrasso G, Padula A, Ventriglia F, Werner B, Colloridi V (1997) Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results. Pediatr Hematol Oncol 14:213-222
-
(1997)
Pediatr Hematol Oncol
, vol.14
, pp. 213-222
-
-
Schiavetti, A.1
Castello, M.A.2
Versacci, P.3
Varrasso, G.4
Padula, A.5
Ventriglia, F.6
Werner, B.7
Colloridi, V.8
-
28
-
-
0037096826
-
2002 Update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology
-
Schuchter LM, Hensley ML, Meropol NJ, Winer EP (2002) 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 20:2895-2903
-
(2002)
J Clin Oncol
, vol.20
, pp. 2895-2903
-
-
Schuchter, L.M.1
Hensley, M.L.2
Meropol, N.J.3
Winer, E.P.4
-
29
-
-
0031722185
-
Strategies for reduction of anthracycline cardiac toxicity
-
Speyer J, Wasserheit C (1998) Strategies for reduction of anthracycline cardiac toxicity. Semin Oncol 25:525-537
-
(1998)
Semin Oncol
, vol.25
, pp. 525-537
-
-
Speyer, J.1
Wasserheit, C.2
-
30
-
-
0025850827
-
Cardiac toxicity 4 to 20 years after completing anthracycline therapy
-
Steinherz LJ, Steinherz PG, Tan CHTC, Heller G, Murphy ML (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266:1672-1677
-
(1991)
JAMA
, vol.266
, pp. 1672-1677
-
-
Steinherz, L.J.1
Steinherz, P.G.2
Tan, C.H.T.C.3
Heller, G.4
Murphy, M.L.5
-
31
-
-
0026557788
-
Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group
-
Steinherz LJ, Graham T, Hurwitz R et al (1992) Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 89:942-948
-
(1992)
Pediatrics
, vol.89
, pp. 942-948
-
-
Steinherz, L.J.1
Graham, T.2
Hurwitz, R.3
-
32
-
-
0029002097
-
Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients
-
Steinherz LJ, Steinherz PG, Tan CH (1995) Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 24:352-361
-
(1995)
Med Pediatr Oncol
, vol.24
, pp. 352-361
-
-
Steinherz, L.J.1
Steinherz, P.G.2
Tan, C.H.3
-
33
-
-
0031917805
-
The prevention of anthracycline cardiomyopathy
-
Steinherz LJ, Wexler LH (1998) The prevention of anthracycline cardiomyopathy. Prog Pediatr Cardiol 8:97-107
-
(1998)
Prog Pediatr Cardiol
, vol.8
, pp. 97-107
-
-
Steinherz, L.J.1
Wexler, L.H.2
-
34
-
-
0029586902
-
New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function - A study in normals and dilated cardiomyopathy
-
Tei CH, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 26:357-366
-
(1995)
J Cardiol
, vol.26
, pp. 357-366
-
-
Tei, C.H.1
Ling, L.H.2
Hodge, D.O.3
Bailey, K.R.4
Oh, J.K.5
Rodeheffer, R.J.6
Tajik, A.J.7
Seward, J.B.8
-
35
-
-
0017354816
-
Daunomycin-induced cardiotoxicity in children and adults
-
Von Hoff DD, Rozencweig M, Layard M, Slavik M, Muggia FM (1977) Daunomycin-induced cardiotoxicity in children and adults. Am J Med 62:200-208
-
(1977)
Am J Med
, vol.62
, pp. 200-208
-
-
Von Hoff, D.D.1
Rozencweig, M.2
Layard, M.3
Slavik, M.4
Muggia, F.M.5
-
36
-
-
0018716636
-
Risk factors for doxorubicin-induced congestive heart failure
-
Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717
-
(1979)
Ann Intern Med
, vol.91
, pp. 710-717
-
-
Von Hoff, D.D.1
Layard, M.W.2
Basa, P.3
Davis, H.L.4
Von Hoff, A.L.5
Rozencweig, M.6
Muggia, F.M.7
-
37
-
-
9044233260
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin
-
Wexler LH, Andrich MP, Venzon D, Berg SL, McClure LW, Chen CC, Dilsizian V, Avila N, Jarosinski P, Balis FM, Poplack DG, Horowitz ME (1996) Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol 14:362-372
-
(1996)
J Clin Oncol
, vol.14
, pp. 362-372
-
-
Wexler, L.H.1
Andrich, M.P.2
Venzon, D.3
Berg, S.L.4
McClure, L.W.5
Chen, C.C.6
Dilsizian, V.7
Avila, N.8
Jarosinski, P.9
Balis, F.M.10
Poplack, D.G.11
Horowitz, M.E.12
|